Clinical Trials in Los Angeles

Showing 8441-8460 of 16,901 trials

Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma

NCT01962792

A MULTICENTER PHASE 1/2B STUDY OF THE BRUTON'S TYROSINE KINASE INHIBITOR, IBRUTINIB (PCI-32765), IN COMBINATION WITH CARFILZOMIB (KYPROLIS™) IN SUBJECTS WITH RELAPSED OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA

Multiple Myeloma

Pharmacyclics LLC.84 participantsStarted Dec 2013

Duarte, California, United States • Los Angeles, California, United States • Denver, Colorado, United States +14 more locations

COMPLETEDNA< 1 mile

E-Cigarettes and SNA

NCT02724241

Randomized controlled trial of electronic cigarettes with nicotine, without nicotine, and sham control, on sympathetic nerve activity and markers of oxidative stress.

Nicotine Dependence

University of California, Los Angeles100 participantsStarted Apr 2015

Los Angeles, California, United States

Study of BTK Inhibitor, Ibrutinib in Combination With Carfilzomib in Subjects With Relapsed and Refractory Multiple Myeloma

E-Cigarettes and SNA

Find Trials by Condition in Los Angeles

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

iCare HOME2 Clinical Trial

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)

Evaluation of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Video Messages and Vaccination Intention

Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

To Assess Pharmacokinetics, Safety and Tolerability of TEV-48125 in Japanese and Caucasian Healthy Subjects After a Single Subcutaneous (SC) Administration of TEV-48125

Study to Evaluate the Safety, Tolerability, and Efficacy of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury

Autologous Dendritic Cells Loaded With Autologous Tumor Associated Antigens for Treatment of Newly Diagnosed Glioblastoma

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

Safety and Efficacy of ADS-5102 in Multiple Sclerosis Patients With Walking Impairment

Comparative Bioavailability of Risperidone

Study of CAD-9303 in Subjects With Schizophrenia

Restore EF Observational Study

A Study of Gantenerumab in Participants With Prodromal Alzheimer's Disease

A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes

Randomized Endo-Vein Graft Prospective

Deep Phenotyping in Patients With ALS